TPTF actively supports the growth of its portfolio companies by working closely with their leadership from various regions. With a focus on disruptive platform technologies, TPTF invests in sectors where it has deep domain expertise, including advanced materials, health/life sciences, ICT, IoT, and robotics/automation. The fund has a multi-stage investment strategy and seeks to invest in companies across Asia, North America, and Europe. Since its founding in 2014, TPTF has become a significant player in the venture capital space, with notable portfolio startups such as Finch Therapeutics Group, Kata.ai, and Heal.